Kalpana Shah

This inventor holds 20 USPTO granted patents and 9 published patent applications, plus 7 CIPO patents and 8 EPO patents, primarily in Immunotherapy Molecules. Top assignee: Macrogenics, Inc.. Active years: 2018-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kalpana Shah. Retrieved from https://idiyas.com/inventor/kalpana-shah

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 20 (Patent Applications = 9)

% Patents Active = 90.0

CIPO Patents = 7 (Patent Applications = 4)

EPO Patents = 8 (Patent Applications = 17)

Average Co-Inventor Count = 6.3

ph-index = 4

Forward Citations = 56(Granted Patents)

Location History:

Rockville, MD (US) (2023)
Boyds, MD (US) (2018 - 2024)

Company Filing History:

20 out of 133

Macrogenics, Inc.

patents

Years Active: 2018-2026

Loading Chart...

Areas of Expertise:

PD-1

LAG-3

Binding Molecules

Immunotherapy

Bispecific

Tri-Specific

Cancer Antigens

Polypeptides

Monovalent

Diabodies

Multivalent

20 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12600779 - LAG-3-Binding Molecules and Methods of Use Thereof (2026-04-14),

2. 12534531 - PD-1-BINDING MOLECULES AND METHODS OF USE THEREOF (2026-01-27),

3. 12435155 - CD137 binding molecules and uses thereof (2025-10-07),

4. 11858991 - LAG-3-binding molecules and methods of use thereof (2024-01-02),

5. 11840571 - Methods of using bispecific molecules having immunoreactivity with PD-1 and CTLA-4 (2023-12-12),

6. 11820818 - Multi-chain polypeptide-containing tri-specific binding molecules (2023-11-21),

7. 11697684 - Tri-specific binding molecules that specifically bind to multiple cancer antigens (2023-07-11),

8. 11623959 - PD-1-binding molecules and methods of use thereof (2023-04-11),

9. 11384149 - Bi-specific monovalent Fc diabodies that are capable of binding CD32B and CD79b and uses thereof (2022-07-12),

10. 11098119 - Covalently bonded diabodies having immunoreactivity with PD-1 and LAG-3, and methods of use thereof (2021-08-24),

11. 11072653 - LAG-3-binding molecules and methods of use thereof (2021-07-27),

12. 10954301 - Bispecific molecules having immunoreactivity with PD-1 and CTLA-4, and methods of use thereof (2021-03-23),

13. 10858430 - Bi-specific monovalent diabodies that are capable of binding to gpA33 and CD3, and uses thereof (2020-12-08),

14. 10647768 - Multi-chain polypeptide-containing tri-specific binding molecules (2020-05-12),

15. 10633440 - Multi-chain polypeptide-containing tri-specific binding molecules that specifically bind to multiple cancer antigens (2020-04-28),

Title: Kalpana Shah - Pioneering Inventor from Boyds, MD

Introduction: Kalpana Shah is a trailblazing inventor based in Boyds, MD, known for her innovative contributions to various industries.

Latest Patents: Kalpana Shah holds several patents in the fields of biotechnology, healthcare devices, and sustainable energy solutions.

Career Highlights: With a career spanning over two decades, Kalpana Shah has been instrumental in developing cutting-edge technologies that have revolutionized the way we approach healthcare and environmental sustainability.

Collaborations: Throughout her career, Kalpana Shah has collaborated with leading research institutions, universities, and companies to bring her inventions to life and make a positive impact on society.

Conclusion: Kalpana Shah's dedication to innovation and her passion for creating solutions to real-world problems make her a true inspiration in the world of inventors.

Profile summary based on public USPTO records.